Pages that link to "Q39821262"
Jump to navigation
Jump to search
The following pages link to Regulation of BCRP (ABCG2) and P-glycoprotein (ABCB1) by cytokines in a model of the human blood-brain barrier (Q39821262):
Displaying 50 items.
- Blood-brain barrier integrity and glial support: mechanisms that can be targeted for novel therapeutic approaches in stroke (Q26864317) (← links)
- Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance (Q26865927) (← links)
- Neuroinflammation: a common pathway in CNS diseases as mediated at the blood-brain barrier (Q27022365) (← links)
- 3D in vitro modeling of the central nervous system (Q27026457) (← links)
- Tissue biodistribution of intravenously administrated titanium dioxide nanoparticles revealed blood-brain barrier clearance and brain inflammation in rat (Q28387762) (← links)
- Specific increase in MDR1 mediated drug-efflux in human brain endothelial cells following co-exposure to HIV-1 and saquinavir (Q28534049) (← links)
- A novel blood-brain barrier co-culture system for drug targeting of Alzheimer's disease: establishment by using acitretin as a model drug (Q28540639) (← links)
- Genetic and epigenetic changes in host ABCB1 influences malaria susceptibility to Plasmodium falciparum. (Q33579831) (← links)
- ABCG2 polymorphisms in gout: insights into disease susceptibility and treatment approaches (Q33602553) (← links)
- Regulation of P-glycoprotein by human immunodeficiency virus-1 in primary cultures of human fetal astrocytes (Q33684254) (← links)
- Quantitative targeted proteomics for membrane transporter proteins: method and application (Q33803962) (← links)
- Evaluation of [(11)C]oseltamivir uptake into the brain during immune activation by systemic polyinosine-polycytidylic acid injection: a quantitative PET study using juvenile monkey models of viral infection (Q33909405) (← links)
- Mesenchymal stem cell-induced doxorubicin resistance in triple negative breast cancer. (Q34012393) (← links)
- Analysis of the mdr-1 gene in patients co-infected with Onchocerca volvulus and Loa loa who experienced a post-ivermectin serious adverse event (Q34030191) (← links)
- Pro-inflammatory cytokine regulation of P-glycoprotein in the developing blood-brain barrier (Q34413660) (← links)
- Tumor necrosis factor alpha increases P‐glycoprotein expression in a BME‐UV in vitro model of mammary epithelial cells (Q34557503) (← links)
- Alterations in function and expression of ABC transporters at blood-brain barrier under diabetes and the clinical significances (Q34669279) (← links)
- Functional genomics reveals an essential and specific role for Stat1 in protection of the central nervous system following herpes simplex virus corneal infection (Q35599416) (← links)
- Pharmacokinetics of antiretrovirals in mucosal tissue (Q35838594) (← links)
- Regulation of ABC efflux transporters at blood-brain barrier in health and neurological disorders (Q36378047) (← links)
- The androgen metabolite, 5α-androstane-3β,17β-diol, decreases cytokine-induced cyclooxygenase-2, vascular cell adhesion molecule-1 expression, and P-glycoprotein expression in male human brain microvascular endothelial cells (Q36439650) (← links)
- SPARC expression by cerebral microvascular endothelial cells in vitro and its influence on blood-brain barrier properties (Q37223975) (← links)
- The Changes of P-glycoprotein Activity by Interferon-γ and Tumor Necrosis Factor-α in Primary and Immortalized Human Brain Microvascular Endothelial Cells (Q37224573) (← links)
- Inflammation and Immune Regulation as Potential Drug Targets in Antidepressant Treatment. (Q37310533) (← links)
- P-glycoprotein trafficking at the blood-brain barrier altered by peripheral inflammatory hyperalgesia. (Q37364487) (← links)
- Immortalized human brain endothelial cell line HCMEC/D3 as a model of the blood-brain barrier facilitates in vitro studies of central nervous system infection by Cryptococcus neoformans (Q37410097) (← links)
- Effect of HIV infection and menopause status on raltegravir pharmacokinetics in the blood and genital tract (Q37592039) (← links)
- Cytokine signaling modulates blood-brain barrier function (Q37612092) (← links)
- Multidrug resistance in the chronic lymphoproliferative disorders (Q37771031) (← links)
- Looking at the blood–brain barrier: Molecular anatomy and possible investigation approaches (Q37777780) (← links)
- Inflammation-mediated changes in drug transporter expression/activity: implications for therapeutic drug response (Q37964754) (← links)
- Cytokines as molecular targets for aryl hydrocarbon receptor ligands: implications for toxicity and xenobiotic detoxification (Q38066512) (← links)
- The hCMEC/D3 cell line as a model of the human blood brain barrier (Q38093329) (← links)
- Phase 0 and phase III transport in various organs: combined concept of phases in xenobiotic transport and metabolism (Q38183877) (← links)
- An observational study examining the effects of a surgically induced inflammatory response on the distribution of morphine and its metabolites into cerebrospinal fluid. (Q38678007) (← links)
- In vitro models of the blood-brain barrier: An overview of commonly used brain endothelial cell culture models and guidelines for their use. (Q38730069) (← links)
- The pivotal role of astrocytes in an in vitro stroke model of the blood-brain barrier (Q38941062) (← links)
- Marked differences in the effect of antiepileptic and cytostatic drugs on the functionality of P-glycoprotein in human and rat brain capillary endothelial cell lines (Q39029172) (← links)
- Cytokine-induced changes in the gene expression profile of a human cerebral microvascular endothelial cell-line, hCMEC/D3 (Q39094145) (← links)
- Temozolomide down-regulates P-glycoprotein in human blood-brain barrier cells by disrupting Wnt3 signaling (Q39138906) (← links)
- Increasing BMI is associated with reduced expression of P-glycoprotein (ABCB1 gene) in the human brain with a stronger association in African Americans than Caucasians. (Q39145955) (← links)
- Cilostazol strengthens barrier integrity in brain endothelial cells (Q39229705) (← links)
- Opioids and the blood-brain barrier: a dynamic interaction with consequences on drug disposition in brain. (Q39285381) (← links)
- Antibiotic Distribution into Cerebrospinal Fluid: Can Dosing Safely Account for Drug and Disease Factors in the Treatment of Ventriculostomy-Associated Infections? (Q40047150) (← links)
- Immunity and inflammation in neurodegenerative diseases (Q43104143) (← links)
- Effect of colibacillosis or coccidiosis on expression of breast cancer resistance protein in small intestine and liver of chickens (Q44398017) (← links)
- Computational prediction of blood-brain barrier permeability using decision tree induction. (Q45076681) (← links)
- Assessing the Impact of Lithium Chloride on the Expression of P-Glycoprotein at the Blood-Brain Barrier. (Q48354738) (← links)
- Drug transport into the central nervous system: using newer findings about the blood-brain barriers (Q48489678) (← links)
- Neuroimmune Axes of the Blood-Brain Barriers and Blood-Brain Interfaces: Bases for Physiological Regulation, Disease States, and Pharmacological Interventions. (Q52689036) (← links)